Anti-Leukemic Activity of Brassica-Derived Bioactive Compounds in HL-60 Myeloid Leukemia Cells

Abstract

Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells mainly treated with chemotherapy for cancer remission, but this non-selective treatment also induces numerous side effects. Investigations with bioactive compounds from plant-derived foods against cancer have increased in the last years because there is an urgent need to search for new anti-leukemic agents possessing higher efficacy and selectivity for AML cells and fewer negative side effects. In this study, we analyzed the anti-leukemic activity of several phytochemicals that are representative of the major classes of compounds present in cruciferous foods (glucosinolates, isothiocyanates, hydroxycinnamic acids, flavonols, and anthocyanins) in the human acute myeloid leukemia cell line HL-60. Our results revealed that among the different Brassica-derived compounds assayed, sulforaphane (SFN) (an aliphatic isothiocyanate) showed the most potent anti-leukemic activity with an IC50 value of 6 µM in dose-response MTT assays after 48 h of treatment. On the other hand, chlorogenic acid (a hydroxycinnamic acid) and cyanidin-3-glucoside (an anthocyanin) also displayed anti-leukemic potential, with IC50 values of 7 µM and 17 µM after 48 h of incubation, respectively. Importantly, these compounds did not show significant cell toxicity in macrophages-like differentiated cells at 10 and 25 µM, indicating that their cytotoxic effects were specific to AML cancer cells. Finally, we found that these three compounds were able to induce the NRF2/KEAP1 signaling pathway in a dose-dependent manner, highlighting SFN as the most potent NRF2 activator. Overall, the present evidence shed light on the potential for using foods and ingredients rich in anticancer bioactive phytochemicals from Brassica spp.

Dasatinib and Hesperidin Loaded Nano Formulation and Preclinical Evaluation for Anticancer Activity

“…The computation was done by monitoring the absorbance at 540 nm using microplate reader (Mark-Bio-Rad), results were calculated using following equation. 39…”

TRIP13 Plays an Important Role in the Sensitivity of Leukemia Cell Response to Sulforaphane Therapy

“…Sulforaphane (SFN), 1-isothiocyanato-4-methylsulfinyl-butane, is an isothiocyanate found in cruciferous vegetables, which is one of the most characterized isothiocyanate compounds and has shown anticancer properties. Recent studies demonstrated that SFN acted as a therapeutic agent in various cancers − and especially played an important role in the treatment of leukemia. − Acute myeloid leukemia (AML) is a hematologic malignancy with high mortality rates, and it is a heterogeneous disease characterized by blocked differentiation and uncontrolled proliferation of blasts . Because of the self-renewal capability of leukemia stem cells, there is a high relapse ratio in AML.…”

Alternativas de conservación y procesamiento de brócoli para la preservación de componentes bioactivos

“…De los compuestos de hidrólisis más estudiados, el principal ha sido el sulforafano, producto de la hidrólisis de la glucorafanina que suele ser uno de los GSL más abundantes en el brócoli (Houghton, 2019;Ruiz-Alcaraz et al, 2022). El sulforafano puede interferir en varias rutas de señalización celular: inhibición de enzimas que activan la carcinogénesis, inducción de enzimas detoxificadoras de carcinógenos, aumento de la apoptosis, paralización de la progresión del ciclo celular y otros mecanismos que aún no están del todo dilucidados, pero que se unen a las evidencias previas de la capacidad del sulforafano para actuar en las diferentes etapas del desarrollo del cáncer, desde la iniciación y la progresión, hasta la apoptosis (Núñez-Sánchez et al, 2022).…”